Revolutionizing Metabolic Health: The Therapeutic Potential of Next-Generation Probiotic Akkermansia Strains (Z62, IR119) for Metabolic Syndromes
The human gut microbiome is integral to digestion, overall health, and metabolic disorder imbalances. Recent advancements in fecal microbiota transplantation (FMT) have highlighted the therapeutic promise of restoring healthy gut microbiota in populations with high incidences of diseases. Focusing on fecal DNA samples from healthy Asian individuals, this study examines the potential of novel Akkermansia strains, specifically Akkermansia muciniphila (Z62) and Akkermansia massiliensis (IR119), as next-generation probiotics for mitigating metabolic syndrome. A key aspect of the study is the investigation of short-chain fatty acids (SCFAs), which are produced and play a crucial role in regulating metabolic processes. SCFAs such as butyrate, acetate, and propionate are essential for energy provision to colon cells and exerting anti-inflammatory effects. The methodology involves selecting two Akkermansia strains, analyzing them through 16S rRNA and WGS, evaluating their growth and survival rates under acidic and bile-salt conditions, alongside their cell adhesion capabilities. The study focuses on the production of key short-chain fatty acids (SCFAs) and tryptophan derivatives by bacteria in regulating metabolic processes, as well as their anti-inflammatory effects on colon cells. Through in vitro assays, both strains exhibited survival in acidic/bile-rich conditions, though Z62 demonstrated superior adhesion to Caco-2 cells, suggesting a higher colonization potential. Metabolomic analysis revealed both strains produce SCFAs, including propionic and acetic acids, and indole metabolites, such as indole-3-propionic acid and indole-3-acetic acid, which are known to influence lipid metabolism and insulin sensitivity. In adipocyte cell models, IR119 significantly reduced lipid accumulation, while Z62 increased lipid presence. Furthermore, IR119 reduced pro-inflammatory cytokine levels, including IL-6 and TNF-α, suggesting potential for inflammation mitigation. The future potential of IR119 as a therapeutic probiotic is extraordinary in addressing complex metabolic and inflammatory diseases, which open new avenues for managing chronic inflammatory conditions like type 2 diabetes and cardiovascular disease. Future clinical trials could refine IR119’s efficacy, positioning it as a leading probiotic in preventive and therapeutic contexts.
金屬多酚配位奈米載體合成與多功能腫瘤治療法開發
本研究結合奈米合成技術與生物醫學, 利用表沒食子兒茶素沒食子酸酯 (Epigallocatechin gallate, EGCG) 作為載體 調控摻雜Cu2+/Cu3+與 Fe2+/Fe3+之含量 並以π-π交互作用力附載缺氧性抗癌藥物替拉扎明 (Tirapazamine, TPZ) 成功製備出多功能金屬多酚配位奈米顆粒簡稱為EFeCuTPZ。 材料經紫外-可見光譜 (UV-vis),、動態光散射 (DLS) 及掃描式電子顯微鏡 (SEM) 確認其粒徑大小、形貌學與穩定性。利用808 nm和671 nm雷射分析其光熱轉換效率 評估光熱療法效果,。在腫瘤微酸性環境下, EFeCuTPZ可利用高濃度之H2O2行芬頓反應 (Fenton Reaction) 產生高活性之氫氧自由基 (•OH), 展現化學動力療法 (Chemo dynamic-therapy, CDT),。同時, 藉由材料中的Cu²⁺與腫瘤環境中的穀胱甘肽 (Glutathione, GSH)反應減少高活性物質 (Reactive oxygen species, ROS) 的消耗 增強CDT之療效。酸性條件下 TPZ顯著釋放 有助於腫瘤治療。 另外, 細胞實驗顯示EFeCuTPZ具有高生物相容性與治療效果, 成功開發出具CDT,、CT及PTT功能之奈米複合材料 為醫學新興藥物材料提供可能性。
橡實代謝物與飛鼠小腸內生菌共發酵產物之應用
This study primarily investigates the components of food residues in the stomach of flying squirrels and the metabolism of the intestinal bacteria Floricoccus tropicus. Using nuclear magnetic resonance (NMR) hydrogen spectrum analysis, the signals of long-chain fatty acids were detected in both n-hexane and 75% ethanol extracts of flying squirrel gastric residues and acorns, suggesting that acorns may be a primary food source for the flying squirrels. The study also identified Floricoccus tropicus, one of the lactic acid bacteria, from the intestines of flying squirrels and discovered its role in the metabolism of fatty acids in acorns. Results showed that polyunsaturated fatty acids significantly decreased during fermentation, indicating that they were converted into short-chain fatty acids with anti-inflammatory properties. In the antibacterial activity experiments, the acorn grease showed no inhibitory effects before fermentation, but after fermentation, the acorn grease exhibited inhibitory effects against E. coli. Furthermore, in anti-inflammatory tests, fermented acorn grease samples significantly suppressed the production of NO and TNF-α in LPSinduced RAW 264.7 cells, with greater inhibition at higher concentrations. In conclusion, the lactic acid bacteria Floricoccus tropicus was found to metabolize fatty acids of acorns into compounds with antibacterial and anti-inflammatory effects.